Economic Impact of Dengue Illness in the Americas
Top Cited Papers
Open Access
- 4 February 2011
- journal article
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 84 (2), 200-207
- https://doi.org/10.4269/ajtmh.2011.10-0503
Abstract
The growing burden of dengue in endemic countries and outbreaks in previously unaffected countries stress the need to assess the economic impact of this disease. This paper synthesizes existing studies to calculate the economic burden of dengue illness in the Americas from a societal perspective. Major data sources include national case reporting data from 2000 to 2007, prospective cost of illness studies, and analyses quantifying underreporting in national routine surveillance systems. Dengue illness in the Americas was estimated to cost $2.1 billion per year on average (in 2010 US dollars), with a range of $1–4 billion in sensitivity analyses and substantial year to year variation. The results highlight the substantial economic burden from dengue in the Americas. The burden for dengue exceeds that from other viral illnesses, such as human papillomavirus (HPV) or rotavirus. Because this study does not include some components (e.g., vector control), it may still underestimate total economic consequences of dengue.Keywords
This publication has 48 references indexed in Scilit:
- Health and economic impact of rotavirus vaccination in GAVI-eligible countriesBMC Public Health, 2010
- High Dengue Case Capture Rate in Four Years of a Cohort Study in Nicaragua Compared to National Surveillance DataPLoS Neglected Tropical Diseases, 2010
- The Epidemiology of Dengue in the Americas Over the Last Three Decades: A Worrisome RealityThe American Journal of Tropical Medicine and Hygiene, 2010
- Barriers to Generalizability of Health Economic Evaluations in Latin America and the Caribbean RegionPharmacoEconomics, 2009
- The Neglected Tropical Diseases of Latin America and the Caribbean: A Review of Disease Burden and Distribution and a Roadmap for Control and EliminationPLoS Neglected Tropical Diseases, 2008
- Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countriesVaccine, 2008
- DengueThe Lancet, 2007
- Dengue Prevention and 35 Years of Vector Control in SingaporeEmerging Infectious Diseases, 2006
- Impacto económico del dengue y del dengue hemorrágico en el Estado de Zulia, Venezuela, 1997-2003Revista Panamericana de Salud Pública, 2006
- Probabilistic Sensitivity Analysis Using Monte Carlo SimulationMedical Decision Making, 1985